Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report, Neurochemistry
Case Report, Neuropathology
Case Report, Psychiatry
Case Report, Psychopharmacology
Case Series, Neurophysiology
Case Series, Psychiatry
Case Series, Psychopharmacology
Editorial
Editorial, Psychiatry
Guest Editorial
Letter to Editor, Neurophysiology
Letter to Editor, Psychiatry
Original Article, Neuromodulation
Original Article, Neurophysiology
Original Article, Neuropsychology
Original Article, Psychiatry
Presidential Address
Presidential Address, Psychiatry
Review Article, Neurochemistry
Review Article, Neuropathology
Review Article, Psychiatry
Reviewers
Viewpoint, Psychiatry
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Case Report, Neurochemistry
Case Report, Neuropathology
Case Report, Psychiatry
Case Report, Psychopharmacology
Case Series, Neurophysiology
Case Series, Psychiatry
Case Series, Psychopharmacology
Editorial
Editorial, Psychiatry
Guest Editorial
Letter to Editor, Neurophysiology
Letter to Editor, Psychiatry
Original Article, Neuromodulation
Original Article, Neurophysiology
Original Article, Neuropsychology
Original Article, Psychiatry
Presidential Address
Presidential Address, Psychiatry
Review Article, Neurochemistry
Review Article, Neuropathology
Review Article, Psychiatry
Reviewers
Viewpoint, Psychiatry
View/Download PDF

Translate this page into:

Review Article
Psychiatry
3 (
1
); 4-10
doi:
10.25259/ABP_16_2024

Beyond the high: Exploring addiction to non-psychoactive substances

Department of Psychiatry, Jawaharlal Nehru Medical College and Hospital, Uttar Pradesh, India
Department of Psychiatry, Fakir Mohan Medical College and Hospital, Balasore, Odisha, India
Department of Era’s Lucknow Medical College and Hospital, Lucknow, Uttar Pradesh, India
Author image

*Corresponding author: Jitendra Kumar, Department of Psychiatry, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India. jnikumarjitendra24@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Kumar J, Shaan F, Naik PK, Reyazuddin M, Ahsan M. Beyond the high: Exploring addiction to non-psychoactive substances. Arch Biol Psychiatry. 2025;3:4-10. doi: 10.25259/ABP_16_2024

Abstract

Psychoactive substance use and resultant addictive behaviors are inherent dynamic processes. Continuous drug abuse alters the very structure and chemical makeup of the brain. In contrast to available addictive substances, non-psychoactive drug use has grown in popularity both culturally and medically. In addition to their legitimate medical uses, many medications are often used in high doses to treat certain medical conditions. The question arises as to whether the medications being prescribed by the physician or over-the-counter supplements are used by the client appropriately or if they are being inappropriately prescribed or used. The abuse of medically available substances is on the rise, leading to potential physiological and psychological dependence. Genetic susceptibility and environmental factors play a significant role in addiction to non-psychoactive substances (NPS). Even though the concept of addiction to NPS may appear misleading, it is apparent that dependency on these substances is a legitimate and significant concern.

Keywords

Abuse
Addiction
DSM-5
ICD10
Non-psychoactive substance

INTRODUCTION

Addiction is a process that seldom remains constant. As addiction develops, it becomes a way of life, often consuming a person’s energy and resources to the point of being destructive and even fatal.[1] Addiction is a set of experiences wherein a person with an addiction undergoes several physiological, psychological, and social changes that influence their behavior. In response to these changes, the person with an addiction begins to act out in particular ways.[2] In recent years, addictive disorders have emerged as one of the most serious health problems globally. Chronic drug abuse eventually alters the very structure and chemical makeup of the brain, resulting in a plethora of psychiatric disorders.

Drug addiction is characterized by a pathological desire for drugs, where drug-seeking and drug-taking behaviors dominate an individual’s thoughts, time, and energy. Initially, people experiment with drugs for a variety of reasons, a key one being that most drugs of abuse produce feelings of pleasure and/or remove feelings of stress and emotional pain. Despite stating a desire to quit and facing many adverse consequences, people with addiction find it difficult to control their frequency of drug use and/or terminate it.[3]

Non-psychoactive substances (NPS) include laxatives, growth hormone, anabolic steroids, non-steroidal anti-inflammatory drugs, as well as proprietary or over-the-counter medicines and folk remedies. Non-medical use of these substances may lead to individual harm through direct toxic effects on organs or infections due to a harmful route of administration (e.g., intravenous self-administration). Dependency on NPS does not entail intoxication, dependence, or withdrawal syndromes, nor is it an acknowledged cause of substance-induced mental disorders.[4]

NON-PSYCHOACTIVE SUBSTANCE USE: A COMPARATIVE NOSOLOGY

Concept of non-psychoactive substance use in the diagnostic and statistical manual of mental disorders (DSM-5)

  • Substance use disorder (SUD) in DSM-5 combines the DSM-IV categories of substance “abuse” and “dependence” into a single disorder measured along a single continuum. Severity specifiers based on the fulfillment of 11 diagnostic features of SUD have also been incorporated: Mild (2 or more), moderate (4 or more), or severe (6 or more).[5]

  • Apart from the substances that the International Classification of Diseases (ICD) covers, DSM-5 categorizes OTHER (or UNKNOWN) substance-related disorders (292.9), wherein it incorporates anti-Parkinsonian medications, nitrous oxide, betel nut, and kava. It also considers culture-related issues that may be associated with the use of indigenous substances within a cultural region.[6]

“PHYSIOLOGICAL” AND “PSYCHOLOGICAL” ADDICTION: IS NON-PSYCHOACTIVE SUBSTANCE USE DIFFERENT?

The general public, as well as many health experts, acknowledge “physiological addiction” and “psychological addiction” as fundamentally different concepts. “Physiological addiction” is described as an addictive behavior that results in bodily withdrawal symptoms upon stoppage. These include nausea, tremors, piloerection, seizures, and so on. Contrary to this, “Psychological addiction” implies compulsive drug use associated with craving, urge, and continued substance use despite significant adverse effects, as well as affective distress upon cessation.[7] Dependency on NPS does not entail intoxication, dependence, or withdrawal syndromes. Furthermore, it is not recognized as a major contributing factor to Substance-Induced Mental Disorders, which are conditions triggered using psychoactive substances.[4]

RECOGNIZING AN ADDICTION PROBLEM IN THE POPULATION

Identifying why certain individuals are more susceptible to addiction remains challenging. Addictive behaviors do not differentiate based on race, ethnicity, education, height, weight, or social status. Moreover, pinpointing the precise cause of addiction is a daunting endeavor. The risk factors for addiction to psychoactive and NPS are not contingent upon an individual’s moral principles or upbringing. The transition from social use to addiction may stem from a combination of diverse factors:[8]

Genetics

Hereditary factors play a significant role, accounting for an estimated 40–60% of addiction risk. Individuals with an addictive personality may be more prone to various addictions.

Environment

Environmental factors, such as parental neglect, abuse, and peer pressure, contribute to addiction risk. Avoiding triggering situations or people is often necessary for those in recovery.

Dual diagnosis

The term “dual diagnosis” is used for individuals who have both an addiction and a mental health disorder. Addiction can be exacerbated by underlying mental health issues, creating a vicious cycle with negative consequences. Likewise, medical conditions can also increase one’s risk of addiction. An individual taking prescription pain pills after surgery may develop an addiction to them. Furthermore, it is also possible for an injury or illness to drastically change a person’s lifestyle, leading to a dependency on drugs or alcohol as a coping mechanism.

Drug type and method of administration

The substance abused and its method of administration influence the speed and severity of addiction. The faster the addiction progresses, the worse the outcome, including a fatal overdose. The drug’s route of administration can also influence addiction, as some drugs enter the bloodstream and brain without being filtered by the liver, increasing the likelihood of addiction.

Early onset of addictive behavior

Addiction is more likely to develop when it starts early, potentially affecting brain development and increasing the risk of future mental health disorders.

Personality profile

High impulsivity and sensation-seeking, along with low harm avoidance, are associated with substance use and behavioral addictions such as internet addiction and gambling. Factors such as self-directedness and interpersonal conflict may contribute to internet addiction.[9,10]

DEPENDENCE OF VARIOUS NPS

Nonsteroidal anti-inflammatory drug/pain killers/topical pain relief ointments

In recent years, addiction to prescription painkillers (oral/topical) has progressively increased owing to the easy availability of over-the-counter drugs. Possible reasons include:

  • Regular use of pain medications results in increased drug receptors in the brain, followed by subsequent nerve cell degeneration.

  • Taking opiates as a pain reliever prevents the body from producing endorphins (the body’s natural painkillers). When the brain’s nerve cells degenerate, physical dependence on opiates results, whereas dose reduction/drug cessation leads to withdrawal symptoms.[11]

Anabolic steroids

Anabolic steroids are synthetically produced variants of the naturally occurring male hormone testosterone. Durabolin (Nandrolone), Deca-Durabolin (Nandrolone Decanoate), Equipoise (Boldenone undecylenate), and Winstrol (stanozolol) are some of the most abused anabolic steroids. Common street (slang) names for anabolic steroids include gym candy, pumpers, stackers, weight trainers, and juice. Bodybuilders, athletes, fitness buffs, and people requiring enhanced physical strength (bodyguards, construction workers, and law enforcement officers) often use anabolic steroids to boost their performance. In addition to increasing lean body mass, strength, and aggressiveness, steroids reduce recovery time between workouts, making it possible to train harder with greater strength and endurance. Non-athletes use steroids to build muscle mass and reduce body fat, which they believe improves personal appearance.[12]

Laxatives

Historically, laxative use has been an integral part of medical therapy. However, they are widely abused, and people are becoming dependent on them.[13] People habituated to using laxatives can be grouped as:

  • First and foremost, 10–60% of patients with eating disorders tend to abuse laxatives (for inducing diarrhea) to feel thinner and lose weight by getting rid of unnecessary calories.[14] They mistakenly believe that laxatives prevent calorie absorption and weight gain by rushing food and calories through their gut. This abuse sets up a vicious cycle of dehydration (secondary to fluid loss) and fluid retention (renin-angiotensin response to dehydration), resulting in reusing laxatives to dehydrate themselves and lose fluid weight. As bowel refractoriness sets in, laxative dose escalation is needed to get the same effect.[15] Stimulants are the most abused laxatives due to relatively high fecal discharge compared to other laxatives.[16]

  • Second, middle-aged or elderly persons often use laxatives to relieve constipation but eventually end up overusing them to the point of bowel refractoriness.[17]

  • The third group consists of individuals involved in sports or athletic training with set weight limits. The sub-group here that has perhaps been best characterized includes wrestlers, who take laxatives to drop weight.[18]

  • Finally, there is a group of surreptitious laxative abusers who use it for the sole purpose of inducing factitious diarrhea.[19]

Antidepressants

Most people taking antidepressants do not abuse them. However, certain classes of antidepressants do carry abuse potential. Vulnerable patient populations include those with a history of substance abuse and those in controlled environments. There were reports of MAOI (monoamine oxidase inhibitors) misuse from the 1960s to the 1990s. However, the most misused antidepressant over the past decade has been bupropion, which acts through dual inhibition of norepinephrine and dopamine reuptake, thereby increasing the intrasynaptic concentrations of these neurotransmitters. Bupropion sustained release activates the nucleus accumbens, a key component of the brain reward system implicated in the development of addiction. TCAs (tricyclic antidepressants) primarily inhibit serotoninnorepinephrine reuptake but also block the muscarinic receptors (producing anticholinergic effects), histamine receptors, and alpha-1 and alpha-2 receptors. Tertiary TCAs have prominent anticholinergic/antihistaminergic effects with resultant confusion and/or delirium when misused.[20]

Herbal derivatives

The term “herb” refers to any plant that is grown for cooking, medicinal, or in some cases, for spiritual purposes. Certain plants can induce psychotic, stimulant, sedative, euphoric, and anticholinergic effects when abused. Such herbal substances that induce a high should be labeled as “dangerous” due to their potential for addiction and cognitive decline with prolonged use.[21]

Hallucinogens

  • Salvia divinorum: The active ingredients of S. divinorum include diterpene and salvinorin-A (k-agonist). When smoked, its effect appears within 1 min and lasts for 15 min or less. It causes psychedelic-like changes such as mood fluctuations, altered perceptions, somatic sensations, and alterations in the perception of external reality and the self.[22]

  • Nutmeg: The active ingredients of nutmeg include eugenol, borneol, linalool, and many amphetamine derivatives, which have psychotropic and sympathomimetic effects lasting up to 24 h.[23] When taken in large doses, nutmeg can be potentially dangerous, causing dizziness, nausea, hot flushes, dry mouth, tachycardia, urinary retention, and constipation. Ingestion of large quantities of nutmeg can lead to “Nutmeg poisoning,” an acute psychiatric disorder characterized by fear of impending doom and/or agitation.[24] There is no specific antidote for nutmeg poisoning, and treatment comprises symptomatic and supportive care.

Anticholinergics

  • Datura stramonium: Also known as Jimson weed, angel’s trumpet, devil’s weed, thorn apple, tolguacha, stinkweed, and moonflower. The active ingredients of Datura include atropine, hyoscyamine, and scopolamine. Mostly abused for its hallucinogenic and euphoric effects, Datura may sometimes cause anticholinergic intoxication, resulting in classic antimuscarinic symptoms due to competitive blockade of acetylcholine at the central and peripheral muscarinic receptor sites. Treatment comprises supportive care, gastrointestinal decontamination (i.e., emesis and/or activated charcoal), and physostigmine in severe cases.

  • Ephedra alkaloids: Ephedra (derived from the plant Ephedra sinica) has long been used as an herbal remedy in traditional Chinese medicine to treat asthma, hay fever, and the common cold.[25] For centuries, Mormons have consumed an ephedra-containing beverage known as “Mormon tea” for its stimulant effect. More recently, it has been used in the form of dietary supplements to boost energy and alertness, enhance athletic performance, and promote weight loss. Ephedra-related toxicity (like other central nervous system stimulants) is treated by addressing central sympathomimetic stimulation, cardiovascular toxicity, and secondary complications caused by the heightened energy state associated with sympathetic stimulation.

  • Betel nut: Nearly 10% of the world population chews betel nuts (Areca catechu), the fourth most abused substance globally after caffeine, alcohol, and nicotine. The areca nut contains tannin, gallic acid, a fixed gum oil, lignin, traces of terpineol, and three main alkaloids, namely arecoline, arecaidine, and guvacine. The pharmacological effects of betel nut are attributed to the alkaloid arecoline, which acts as a cholinomimetic agonist at nicotinic and muscarinic receptors and as a potent inhibitor of the enzyme acetylcholinesterase.[26] No specific antidote is present for toxicity.

  • Yohimbine: A stimulant and aphrodisiac, yohimbine is an alkaloid obtained from the bark of Pausinystalia yohimbe, Corynanthe yohimbe, and Rauwolfia serpentina (Indian Snakeroot). It is marketed as a supplement for bodybuilding, sexual enhancement, and erectile dysfunction despite limited evidence regarding its efficacy.[27]

  • Kava: The drug kava lactones (or pyrones) are derived from the dried roots and rhizome of Piper methysticum. Many South Pacific countries use Kava extract in traditional recreational drinks, whereas in Western societies, it is used as an over-the-counter anxiolytic, muscle relaxant, mood enhancer, or treatment for premenstrual syndrome. Kava enhances the effect of other centrally acting agents such as alcohol and benzodiazepines. Long-term use of kava, especially in high doses (400 mg of kava pyrones daily), has been associated with the development of dry, flaky, yellow skin (kava dermopathy) through an unknown mechanism; the effect may be reversible upon cessation of the drug.[28]

Clove cigarettes

With approximately 30% cloves (Syzygium aromaticum) and 70% tobacco, clove cigarettes contain twice as much tar, nicotine, and carbon monoxide as average cigarettes. There is a misconception among many users that clove cigarettes are herbal/natural alternatives to tobacco. Some are drawn to clove cigarettes in pursuit of “exotic” and unusual experiences. Eugenol, an ingredient in cloves, upon inhalation causes numbness in the throat along with a topical anesthetic effect. In the United States, “Toking” is the most common technique for obtaining enhanced pleasure from clove cigarettes through deep inhalation and increased retention of the smoke. The increasing use of clove cigarettes as a gateway drug among adolescents is quite concerning.[29]

Absinthe

It is an alcoholic beverage made from the extracts of wormwood (Artemisia absinthium), a native European plant that has been naturalized in the United States. Chronic use of absinthe has been linked to “Absinthism,” a condition characterized by hyperexcitability and hallucinations. “Thujone,” a terpene found in the oil of wormwood, is believed to cause these hallucinatory experiences and/or psychosis.[30]

Diuretics

Clinically, diuretics are used to treat hypertension and other cardiovascular disorders. Diuretics are classified as masking agents on the “WADA (World Anti Doping Agency) Prohibited List” due to their illegal use by sportspersons for weight loss and masking (to hide the effects of other prohibited substances).[31] The majority of doping in sports involves the use of diuretics before an anti-doping test. Diuretics increase urine volume and dilute any doping agents as well as their metabolites present in urine, making their detection more difficult by the usual anti-doping tests. Athletes who use diuretics can quickly lose body weight, which is clearly advantageous in sports such as wrestling, boxing, judo, and weightlifting. Female gymnasts and ballet dancers also use diuretics to maintain a low body weight. Caldwell et al. compared the effects of exercise, sauna, and diuretic-induced acute dehydration on weight loss.[32]

Vitamins

Vitamins play a crucial role in maintaining health and strength. An adequate diet is the only way to achieve a full vitamin intake. This is true for many reasons: First, there is no chemical diet that could contribute to the positive effects of a natural diet. Second, concentrated vitamins are far more expensive than their natural counterparts. Furthermore, people get tired or careless about taking pills, while they must always continue to eat food. Vitamin therapy is, however, necessary for the treatment of deficiency states, especially when severe. A physician must prevent their patients from becoming victims of needless and expensive vitamin therapy and psychoeducate them that vitamins are not a panacea for all human ills.[33]

MANAGING NPS ADDICTION

Literature lacks established guidelines for managing addiction to NPS. The current approach focuses on symptomatic management tailored to individual patients, emphasizing motivational counseling and support from family and social networks. Unsupervised digital access to healthcare presents both opportunities and challenges in addressing this issue. Digital platforms offer accessibility to resources for those dealing with NPS use, including education and support. Yet, this access can also promote unsupervised consumption and worsen addiction problems [Table 1].

Table 1: Concept of non-psychoactive substance use in ICD-11 and ICD-10
ICD-11 ICD-10
  • ICD-11 code 6C4H for “Disorders due to use of non-psychoactive substances” is classified under the block 6C4, which includes “Disorders due to substance use.”

  • The list of specific diagnostic categories that apply to non-psychoactive substances includes:

    • 6C4H.0 Episode of harmful use of non-psychoactive substances

    • 6C4H.1 Harmful pattern of use of non-psychoactive substances

    • 6C4H.Y Other specified disorder due to use of non-psychoactive substances

    • 6C4H.Z Disorder due to use of non-psychoactive substances, unspecified

  • Non-psychoactive substances as per ICD-11 include laxatives, anabolic steroids, growth hormone, erythropoietin, non-steroidal anti-inflammatory drugs, and proprietary or over-the-counter medicines and folk remedies.

  • Use of antidepressants, medications with anticholinergic properties (e.g., benztropine), and antihistamines are classified separately under 6C4E “Disorders due to use of other specified psychoactive substances, including medications.”

  • ICD-10 code F55 for “Abuse of non-dependence producing substances” is classified under the block F50-59, which includes “Behavioral syndromes associated with physiological disturbances and physical factors.”

  • It also states that persistent and unjustified use of these substances is usually associated with unnecessary expense, often involves unnecessary contact with medical professionals or supporting staff, and is sometimes marked by the harmful physical effects of the substances. Attempts to discourage the use are often met with resistance

  • Non-psychoactive substances as per ICD-10 include antidepressants (F55.0), laxatives (F55.1), analgesics (F55.2), antacids (F55.3), Vitamins (F55.4), steroids or hormones (F55.5), specific herbal or folk remedies (F55.6), other substances that do not produce dependence (F55.8), and unspecified (F55.9).

ICD-11: International Classification of Diseases, Eleventh Revision, ICD-10: International Classification of Diseases, Tenth Revision.

Managing addiction to NPS often involves addressing underlying issues and behaviors associated with their use. Here are some general steps:

  • Assessment: Evaluate the extent of NPS use and its impact on physical, mental, and social well-being

  • Education: Offer insight into the potential risks and consequences of NPS use

  • Identify triggers: Identifying triggers aids in developing coping strategies

  • Supportive therapy: To address underlying emotional issues, stressors, or co-occurring mental health disorders

  • Behavioral therapy: Implement cognitive-behavioral techniques to modify thoughts and behaviors related to NPS use

It is essential to tailor the treatment approach to the individual’s unique needs and circumstances, considering factors such as their motivation for change, social support network, and readiness to engage in treatment.

CONCLUSION

The use of NPS is a major global public health concern. While the term “non-psychoactive” may imply safety, many of these substances can nevertheless have profound effects on the brain and body, ranging from addiction, self-harm, and mental health issues. This is indicated by the apparently higher usage of these substances worldwide. Unlike addiction to psychoactive substances, which is considered a mental and behavioral disorder, addiction to non-psychoactive drugs is often viewed positively due to their beneficial properties. Moreover, nonpsychoactive drugs are thought to have a constructive effect on behaviors that are essential for survival and reproduction, which may explain their persistent use in human societies. Understanding the neurobiological mechanisms underlying addiction can inform more effective prevention, intervention, and treatment strategies. Furthermore, addressing the growing issue of NPS use and addiction requires a multidisciplinary approach that incorporates advances in neuroscience, digital healthcare, public policy, and education.

Ethical approval:

Institutional Review Board approval is not required.

Declaration of patient consent:

Patient’s consent is not required as there are no patients in this study.

Conflicts of interest:

There are no conflicts of interest.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation:

The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.

Financial support and sponsorship: Nil.

References

  1. . Addiction and change: How addictions develop and addicted people recover New York: Guilford Publications; .
    [Google Scholar]
  2. . Toward a phenomenology of addiction: Embodiment, technology, transcendence. In: Berlin/Heidelberg. Germany: Springer International Publishing; .
    [CrossRef] [Google Scholar]
  3. , , . Drug addiction In: StatPearls. Treasure Island, FL: StatPearls Publishing; . Available from: https://www.ncbi.nlm.nih.gov/books/NBK549783. [Last accessed 2024 December 03]
    [Google Scholar]
  4. . Eleventh Revision (ICD-11), World Health Organization (WHO) . Available from: https://icd.who.int/browse11. [Last accessed 2024 December 03]
    [Google Scholar]
  5. . Diagnostic and statistical manual of mental disorders: DSM-5. Washington, DC: American Psychiatric Association; .
    [CrossRef] [Google Scholar]
  6. . The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines Geneva: World Health Organization; .
    [Google Scholar]
  7. . Are “Physiological” and “psychological” addiction really different? Well, No!… um, er, Yes? Subst Use Misuse. 2008;43:967-71.
    [CrossRef] [PubMed] [Google Scholar]
  8. . Recognizing an addiction problem In: Healthline. California: Healthline Publishing; . Available from: https://www.healthline.com/health/addiction/recognizing-addiction. [Last accessed 2024 December 03]
    [Google Scholar]
  9. , , , , , , et al. Individual differences in drug abuse vulnerability: d-Amphetamine and sensation-seeking status. Psychopharmacology. 2006;189:17-25.
    [CrossRef] [PubMed] [Google Scholar]
  10. , . Pathological gambling and obsessive-compulsive disorder: towards a spectrum of disorders of volition. Braz J Psychiatry. 2007;29:107-17.
    [CrossRef] [PubMed] [Google Scholar]
  11. , . Mental health, pain, and risk of drug misuse: A nationwide cohort study. Addict Behav. 2020;109:106467.
    [CrossRef] [PubMed] [Google Scholar]
  12. , , . Anabolic steroid use disorder In: StatPearls. Treasure Island, FL: StatPearls Publishing; . Available from: https://www.ncbi.nlm.nih.gov/books/NBK538174
    [Google Scholar]
  13. , , , , . Prevalence of self-induced vomiting and laxative/medication abuse among female adolescents: A longitudinal study. Int J Eat Disord. 1993;14:375-8.
    [CrossRef] [PubMed] [Google Scholar]
  14. , , , , , , et al. Features associated with laxative abuse in individuals with eating disorders. Psychosom Med. 2006;68:470-7.
    [CrossRef] [PubMed] [Google Scholar]
  15. , , , . Medical complications of psychiatric illness Washington, DC: American Psychiatric Publishing, Inc.; . p. :228.
    [Google Scholar]
  16. , , , . Laxative abuse in eating disorders. Psychiatr Med. 1989;7:75-87.
    [Google Scholar]
  17. , . Complications of laxative abuse. Ann Rev Med. 1996;47:127-34.
    [CrossRef] [PubMed] [Google Scholar]
  18. , . Weight loss beliefs, practices and support systems for high school wrestlers. J Adolesc Health. 1994;15:410-5.
    [CrossRef] [PubMed] [Google Scholar]
  19. , , . Factitious diarrhea masquerading as refractory celiac disease. South Med J. 2006;99:293-5.
    [CrossRef] [PubMed] [Google Scholar]
  20. , . Abuse and misuse of antidepressants. Subst Abuse Rehabil. 2014;5:107-20.
    [CrossRef] [PubMed] [Google Scholar]
  21. , , , , , . Herbal highs: Review on psychoactive effects and neuropharmacology. Curr Neuropharmacol. 2017;15:750-61.
    [CrossRef] [PubMed] [Google Scholar]
  22. , , , , . Pattern of use and subjective effects of Salvia divinorum among recreational users. Drug Alcohol Depend. 2006;85:157-62.
    [CrossRef] [PubMed] [Google Scholar]
  23. , , . Abuse of nutmeg (Myristica fragrans Houtt): studies on the metabolism and the toxicologic detection of its ingredients elemicin, myristicin, and safrole in rat and human urine using gas chromatography/mass spectrometry. Ther Drug Monit. 2006;28:568-75.
    [CrossRef] [PubMed] [Google Scholar]
  24. . Effects of nutmeg and myristicine. Available from: http://www.erowid.org/plants/nutmeg/html. [Last accessed 2015 July 23]
    [Google Scholar]
  25. , , , . Ephedra in perspective-a current review. Phytother Res. 2003;17:703-12.
    [CrossRef] [PubMed] [Google Scholar]
  26. . A modern herbal resource page. . Available from: http://www.botanicals.com/botanical/mgmh/a/areca.html. [Last accessed 2015 July 23]
    [Google Scholar]
  27. . NCCAM herbs at a glance. . Available at http://nccam.nih.gov/health/yohimbe/html. [Last accessed 2015 July 23]
    [Google Scholar]
  28. . Herbal kava: Reports of liver toxicity. Can Med Assoc J. 2002;166:777.
    [Google Scholar]
  29. . Hazards of clove cigarettes. Pediatrics. 1991;88:395-6.
    [CrossRef] [Google Scholar]
  30. . Absinthe FAQ. Available from http://www.brewery.org/library/absfaq.html. [Last accessed 2025 June 20]
    [Google Scholar]
  31. . The 2009 WADA prohibited list. 2009b. Available from: https://www.wada-ama.org/sites/default/files/resources/files/WADA_Prohibited_List_2009_EN.pdf. [Last accessed 2015 July 23]
    [Google Scholar]
  32. , , . Differential effects of sauna-, diuretic-, and exercise-induced hypohydration. J Appl Physiol. 1984;57:1018-23.
    [CrossRef] [PubMed] [Google Scholar]
  33. . The use and abuse of vitamins in the treatment of mild or early deficiency states. Nutr Rev. 1944;2:353-4.
    [CrossRef] [Google Scholar]
Show Sections